The Takeda Pharmaceutical Co. logo is displayed at the company’s global headquarters in Tokyo, Japan. (Photographer: Kentaro Takahashi/Bloomberg)

Takeda's Long Battle for $62 Billion Shire Deal Gets Victory

(Bloomberg) -- Christophe Weber, the chief executive officer of Takeda Pharmaceutical Co., has faced a string of challenges in his $62 billion pursuit of U.K.-listed drugmaker Shire Plc. The Japane...